BMY - Risk

Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 65/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

7/7 Very High

7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.2x).

Beta (Market Relation)

0.18x

Defensive

Volatility (5Y p.a.)

24.8% p.a.

5-Year Horizon

Max Drawdown (5Y)

-51.1%

5-Year Horizon

Sharpe Ratio

-0.07

Return / Risk

Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Volatility Expansion (3Y > 5Y)

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	+33.8%
3 Years	28.0%	-32.5%	-0.03	+1.7%
5 Years	24.8%	-51.1%	-0.07	+0.8%
10 Years	24.9%	-51.1%	-0.03	+1.8%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 202%.

Historical Stress Test: Maximum peak-to-trough drawdown of -51.1% in the extended horizon.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)

Overall Governance Risk

4 ISS Score: 4 / 10

Audit Risk

4 ISS Score: 4 / 10

Board Risk

8 ISS Score: 8 / 10

Short Ratio

5.36